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http://dxObjectives: Optimal management of poststernotomy mediastinitis is controversial. Negative pressure wound
treatment improves wound environment and sternal stability with low surgical invasiveness. Our protocol
was based on negative pressure followed by delayed surgical closure. The aim of this study was to provide
the results at early follow-up and to identify the risk factors for adverse outcome.
Methods: In 5400 cardiac procedures, 44 consecutive patients with mediastinitis were enrolled in the study.
Mediastinitis treatment was based on urgent debridement and negative pressure as the first-line approach. After
wound sterilization, chest closure was achieved by elective pectoralis muscle advancement flap. Each patient’s
hospital data were collected prospectively. Variables included patient demographics and clinical and biological
data. Acute Physiology and Chronic Health Evaluation (APACHE) II score was calculated at the time of diag-
nosis and 48 hours after debridement. Focus outcome measures were mediastinitis-related death and need for
reintervention after pectoralis muscle closure.
Results: El Oakley type I and type IIIA mediastinitis were the most frequent types (63.6%). Methicillin-
resistant Staphylococcus aureus was present in 25 patients (56.8%). Mean APACHE II score was 19.4  4 at
the time of diagnosis, and 30 patients (68.2%) required intensive care unit transfer before surgical debridement.
APACHE II score improved 48 hours after wound debridement and negative pressure application (mean value,
19.4  4 vs 7.2  2; P ¼ .005) independently of any other variables included in the study. One patient in septic
shock at the time of diagnosis died (2.2%).
Conclusions: Negative pressure promotes a significant improvement in clinical status according to APACHE II
score and allows a successful elective surgical closure. (J Thorac Cardiovasc Surg 2014;148:2397-403)P
MPoststernotomy mediastinitis (PSM) is a rare but life-
threatening complication with an incidence of 1% to
3% of cardiac procedures.1,2 PSM is one of the most
expensive complications in cardiac surgery with a 3-fold in-
crease in overall costs.3 Optimal management is still contro-
versial. The mortality rate remains high, ranging from 5%
to 47%,4-6 with a recurrence of approximately 20%.7
The open wound approach allows infection control by se-
rial wound dressing changes, but the high mortality rate, up
to 45%, induced many centers to abandon this strategy.8
Closed techniques are based on an aggressive surgical
approach. Extensive debridement and primary chest wall
irrigation or suction closure are widely accepted ande Department of Cardiac Surgery, European Hospital, Rome, Italy.
ures: Authors have nothing to disclose with regard to commercial support.
d for publication Feb 18, 2014; revisions received March 31, 2014; accepted
blication April 11, 2014; available ahead of print May 14, 2014.
for reprints: Ruggero De Paulis, MD, Division of Cardiac Surgery, European
ital, via Portuense 700, 00149 Rome, Italy (E-mail: depauli@tin.it).
23/$36.00
ht  2014 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2014.04.025
The Journal of Thoracic and Carachieve immediate chest wall integrity, although wound
closure and infection healing do not coincide.
The introduction of vacuum-assisted closure (VAC)9,10
changed the management of sternal wound complications
toward a less-invasive approach. Negative pressure im-
proves the wound environment and restores sternal stability
with minimal surgical stress and a shorter intensive care
unit (ICU) stay than primary closed or open packing
treatments.11,12
Despite several efforts and a multidisciplinary approach,
the outcome of deep sternal wound infections is often un-
predictable. Mediastinitis is a high-risk condition in which
patient baseline characteristics are worsened by infection,
sternal instability, and recent cardiac surgery. Mediastinitis
mortality risk factors, such as age, renal failure, obesity,
severity of illness, persistently positive bacteremia, and pro-
longed mechanical ventilation after wound debridement,
highlight the frailty of this population.12-14
Over a 6-year period, we have adopted a single protocol
in the treatment of PSM. Our strategy is based on wound
debridement and negative pressure wound treatment
(NPWT) as first-line treatment until wound sterilization,diovascular Surgery c Volume 148, Number 5 2397
Abbreviations and Acronyms
APACHE ¼ Acute Physiology and Chronic Health
Evaluation
CABG ¼ coronary artery bypass grafting
ICU ¼ intensive care unit
MRSA ¼ methicillin-resistant Staphylococcus
aureus
NPWT ¼ negative pressure wound treatment
PMV ¼ prolonged mechanical ventilation
PSM ¼ poststernotomy mediastinitis
VAC ¼ vacuum-assisted closure
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Mfollowed by delayed sternal rewiring and pectoralis muscle
flap closure.
We choose NPWT because it minimizes surgical inva-
siveness. Negative pressure restores sternal stabilization
without the need for adjunctive procedures. Continuous
drainage improves the wound environment and reduces
the bacterial count, allowing a less-invasive approach at
the time of surgical debridement. The aim of this study is
to provide the results of our single protocol at early
follow-up and to identify the risk factors for an adverse
outcome.METHODS
This observational study was conducted in a single cardiac center. Be-
tween April 2006 and September 2013 at the European Hospital of
Rome, 5400 midline sternotomies for cardiac procedures were performed.
Patients with deep sternal dehiscence were assessed in terms of general
signs and symptoms. Fever, sternal instability, and blood tests were first
evaluated. Samples for microbiological investigation were collected from
wound exudation. Computed tomography scan was used to evaluate the
presence of mediastinal or pleural fluid collection.
PSMwas defined according to the guidelines of the US Centers for Dis-
ease Control and Prevention.15 Mediastinitis was then classified according
to El Oakley and Wright16 classification. The Acute Physiology and
Chronic Health Evaluation (APACHE) II score17 was assessed to evaluate
the severity of clinical status before surgical debridement.
Patients with other wound complications, such as superficial wound in-
fections, fat necrosis, and uninfected sternal instability, were excluded
from the study. According to this definition, PSM developed in 44 patients
(0.81%) during the study period, and they were enrolled in the study.
Mediastinitis Management
Intravenous vancomycin 500 mg every 12 hours was started until the
antibiotic regimen was changed according to culture sensitivity and infec-
tologist evaluation. Patients were admitted to the operating room as urgent
cases. Sternal wounds were completely reopened. All sternal wires, bone
samples, sutures, and necrotic and infected tissues were gently removed
and cultured without excessive tissue removal. Procedures were carried
out in a conservative manner with minimal removal of bone tissue. The
entire field was largely irrigated with hydrogen peroxide, saline solution,
and diluted povidone-iodine. When vascular Dacron prostheses were
exposed in the field (2 cases) the great omentum was prepared and fixed
to cover the vascular graft. Hemostasis was accurately completed with
diathermy. A sterile polyurethane foam dressing with an open-pore struc-
ture was tailored to fit in the wound. A first layer was placed in the sternum2398 The Journal of Thoracic and Cardiovascular Surand tailored to completely fit the whole dead space between the 2 sternal
edges (Figure 1). A second layer, placed over the first, was tailored to fit
the whole area between subcutaneous tissues. Both sponges were signifi-
cantly oversized to completely obliterate dead space due to dehiscence af-
ter negative pressure was started. This allows an effective sternal
stabilization that promotes respiratory function and prevents organ injury,
minimizing sternal movement during patients’ mobilization. If needed, 4
layers of paraffin gauzes were placed to protect underlying structures.
The wound was sealed with transparent adhesive drape, and the sponge
was connected to a pump unit with a continuous negative pressure
of 125 mm Hg.
Clinical reassessment was performed immediately after debridement
and daily for the first 3 postoperative days. Subsequent routine examina-
tions were performed as needed.
NPWT dressing was changed every 2 days or whenever drainage ex-
ceeded 200 mL/24 hours in the surgical ward without the need for anes-
thetics. Wound samples were cultured each time, and iodine solution was
used for dehiscence washing. Full patient mobilization and normal dietary
regimen were achieved as soon as possible. After 3 consecutive negative
mediastinal cultures, patients were readmitted to the operating room.
Under general anesthesia, sternal rewiring and bilateral pectoralis mus-
cle flap were performed. Fibrous tissue on the wound edge was removed.
Bilateral pectoralis muscle flap was performed, raising the inner face of
the pectoralis from the sternal and costal insertion to the anterior axillary
line. Superiorly, the dissection stopped at the level of the clavicle. The
pectoralis minor and the humeral insertion of the pectoralis major were
left intact. To minimize closure tensions, a small flap of subcutaneous
tissue was made over the pectoralis plane. Sternal rewiring was achieved
with 6 to 8 simple interrupted stainless-steel wires. Muscles were advanced
to the midline and closed with absorbable interrupted suture (Figure 2).
One drainage was put under each muscle flap.Data Collection
All patients’ hospital data were collected prospectively in our institu-
tional database for surgical wound complications at each patient assess-
ment. Data recorded at the time of wound diagnosis and 48 hours after
debridement were analyzed in the study and are listed in Table 1. Diabetes
was defined as the need for antidiabetic drugs; obesity was defined as body
mass index greater than 30 kg/m2; anemia was defined as hemoglobin level
less than 10 g/dL before debridement; chronic obstructive pulmonary dis-
ease was defined as long-term use of bronchodilators or steroids; arteriopa-
thy was determined by the presence of stenosis greater than 50% on the
limb or carotid arteries; the type of mediastinitis was defined according
to El Oakley and Wright16 classification; the time interval to mediastinitis
presentation was defined as the interval between the initial cardiac surgery
and the mediastinitis diagnosis; and the severity of illness was stratified ac-
cording to the APACHE II score. The microorganism responsible for medi-
astinal infection was defined by the cultures of the mediastinal samples,
and the presence of concomitant bloodstream infection was evaluated by
the results of the blood cultures before wound debridement. Other data
were recorded 48 hours after debridement: (1) APACHE II score value,
(2) persistence of positive wound cultures, and (3) persistently positive
bacteremia, defined as 2 or more positive blood cultures drawn more
than 24 hours after debridement (Table 1).
Primary outcome measures were in-hospital death from any cause,
mediastinitis-related death (defined as death occurring as a consequence
of uncontrollable sepsis, massive mediastinal hemorrhage, or secondary
prosthetic infection), and need for reintervention (defined as need for re-
debridement after pectoralis flap wound closure because of continued local
infection or recurrence of sternal instability).
Secondary outcome measures included the following: life-threatening
complications, defined as secondary endocarditis, massive mediastinal
hemorrhage occurring after debridement, and occurrence of sepsis or
multiple-organ failure; ICU stay, defined as need for ICU surveillancegery c November 2014
FIGURE 1. A, The first layer of sterile polyurethane foam dressing was tailored to largely oversize the dead space between the sternal edges as shown by
thewhite lines. B, The first layer of the sponge is placed between the sternal edges as shown by the arrow. A second layer was oversized to completely fit the
dead space between the presternal tissues (white lines). C, When negative pressure was applied, the whole dead space of the dehiscence was completely
obliterated.
Salica et al Perioperative Managementmore than 24 hours after wound debridement; prolonged mechanical venti-
lation, defined as need for mechanical ventilation more than 24 hours after
debridement; length of stay, calculated after the diagnosis of mediastinitis
even if it occurred during the same hospitalization as the initial cardiac sur-
gery; and time required to sterilize mediastinal samples, calculated as the
interval between the debridement and the first of the 3 consecutive sterile
mediastinal cultures. The European Hospital Institutional Review Board
approved the study design.FIGURE 2. A, Sternal rewiring with interrupted stainless-steel wires and Redon
to the midline and closed with absorbable interrupted suture. C, Final view of
The Journal of Thoracic and CarStatistical Analysis
All data analysis was carried out with SPSS 20.0 (IBMCorp, NewYork,
NY). Data collection was performed prospectively with Excel datasheets
(Microsoft Corp, Redmond, Wash). All binary parameters were standard-
ized to 0 (nonpresence) and 1 (presence) of condition. Contingency
tables were obtained for each dependent parameter in relation to the
following outcome measures: mediastinitis-related death and need for
reintervention. On each table, Pearson K-square test with correction fordrainage under the muscle flap. B, The pectoralis major flaps are advanced
the wound sutured with Donati stitches.
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TABLE 1. Demographic and clinical characteristics of patients at the
time of mediastinitis diagnosis and at 48 hours after debridement and
negative pressure wound treatment application
Variables
General characteristics
Age, mean  SD, y 68.4  10
Male, n (%) 31 (70.4)
Diabetes, n (%) 33 (75)
Obesity, n (%) 11 (25)
COPD, n (%) 20 (45.4)
Chronic dialysis, n (%) 3 (6.8)
CABG alone, n (%) 25 (56.8)
BITA, n (%) 27 (61.3)
At the time of mediastinitis diagnosis
Leukocyte count (mean value, 3103/mm3) 18.8  6
Anemia, n (%) 38 (86.36)
Time interval to mediastinitis presentation, d,
mean  SD
18.91  6
Type of mediastinitis (El Oakley)
I 4 (9.09%)
IIIA 24 (54.54%)
IIIB 12 (27.27%)
IVA 4 (9.09%)
APACHE II score, n 19.4  4
Need for ultrafiltration (new onset), n (%) 4 (9)
MRSA in mediastinal cultures, n (%) 25 (56.8)
Bloodstream infection, n (%) 27 (61.3)
Need for vasoconstrictors, n (%) 15 (29.3)
Septic shock 1 (2.2%)
ICU transfer 30 (68.2%)
48 h after debridement
APACHE II score, mean  SD 7.2  2
Positive mediastinal cultures, (%) 44 (100)
Persistently positive bacteremia, n (%) 22 (50)
APACHE, Acute Physiology and Chronic Health Evaluation; BITA, bilateral internal
thoracic artery; CABG, coronary artery bypass grafting; COPD, chronic obstructive
pulmonary disease; ICU, intensive care unit; MRSA, methicillin-resistant Staphylo-
coccus aureus; SD, standard deviation.
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(Wilcoxon and Student t tests for paired samples) were used to verify dif-
ferences in continuous variables. Preoperative and postprocedural (48 hours
after debridement) APACHE II score value, results of wound cultures, and
results of blood cultures were compared by using the McNemar test. After-
ward, univariate analysis was performed with a binary logistic regression
equation, with 95% confidence interval.
RESULTS
Patients’ Characteristics
The population comprised 31 male and 13 female pa-
tients. The mean patient age was 68.4  10.3 years. The
baseline characteristics are shown in Table 1. Prior cardiac
operation was isolated coronary artery bypass grafting
(CABG) in 25 patients (56.8%); valve procedures or
ascending aortic surgery in 9 patients (20.4%) (re-do sur-
gery in 2); and CABG associated with valve procedures in
10 patients (22.7%). Preoperative risk factors for mediasti-
nitis included obesity (12 patients, 25%), diabetes2400 The Journal of Thoracic and Cardiovascular Sur(75.14%), and chronic obstructive pulmonary disease
(45.4%). The bilateral internal thoracic artery was har-
vested in 61.3% of patients with mediastinitis and was al-
ways associated with 1 or more of the following
comorbidities: obesity, diabetes, or chronic obstructive pul-
monary disease. Renal insufficiency requiring chronic dial-
ysis was present in 3 patients with mediastinitis.
Mediastinitis
The spectrum of encountered organisms was similar
to that in other reports.11,13,14 Methicillin-resistant
Staphylococcus aureus (MRSA) was identified in 25
patients (56.8%), methicillin-susceptible S. aureus was
identified in 4 patients, and coagulase-negative staphylo-
cocci were identified in 4 patients. Gram-negative
organisms were identified in 11 patients (6 were positive
for Pseudomonas aeruginosa and 5 were positive for
Escherichia coli).
The mean time interval to mediastinitis presentation was
18.91 6 days. El Oakley type I and IIIAwere identified in
28 patients (63.6%). Mean APACHE II score was 19.4 4.
Thirty patients (68.2%) required ICU transfer before
surgical debridement. Four patients (9.09%) had acute renal
failure and required ultrafiltration. Concomitant blood-
stream infection was identified in 27 patients (61%). Fifteen
patients had systemic signs of sepsis with the need for
intravenous vasoconstrictors, 1 of whom had septic shock
and required mechanical ventilation before debridement.
Data recorded 48 hours after debridement showed that
the mean APACHE II score was significantly improved
compared with the preoperative value (19.4  4 vs 7.2 
2, P<.005), whereas bloodstream infection and mediastinal
cultures did not show any differences.
Outcome
The overall in-hospital mortality rate was 2.2%
(1/44 patients), and death was directly due to mediastinitis.
The patient was a 74-year-old man with El Oakley type
IIIB mediastinitis. Prior cardiac surgery was a Bentall
procedure. Mediastinal and blood cultures were positive
for MRSA. The patient had signs of septic shock at the
time of mediastinitis diagnosis, and he died of multiorgan
failure 14 days after wound debridement.
The majority of patients (43/44; 97.8%) were extubated
in the operating room after debridement and transferred to
the ward within 24 hours. ICU stay and prolonged mecha-
nical ventilation (PMV) were required in 1 patient (2.2%).
Life-threatening complications occurred in 1 patient who
experienced major mediastinal bleeding caused by a left
internal thoracic artery graft rupture 12 days after NPWT.
The graft was sutured, and the patient underwent a
successful left anterior descending coronary angioplasty.
The length of stay was 24  33 days (range, 9-78 days).
The time required to sterilize mediastinal cultures wasgery c November 2014
TABLE 2. Univariate analyses for mediastinitis-related death
Variable P OR
Lower
CI limit
Upper
CI limit
Age .246 1.056 0.949 1.174
Sex .608 1.029 0.973 1.09
Diabetes .422 1.038 0.964 1.118
Obesity .139 1.077 0.931 1.245
COPD .422 0.963 0.894 1.037
Creatinine>2 .118 1.083 0.926 1.267
Dialysis .784 0.976 0.932 1.024
Vasculopathy .688 0.974 0.924 1.026
Transfusion .536 1.032 0.97 1.099
Anemia .536 1.032 0.97 1.099
BITA .291 0.952 0.866 1.048
Other than CABG alone .246 1.056 0.949 1.174
LOS .749 0.975 0.928 1.025
ICU recovery .091 1.333 0.757 2.348
Inotrope .181 1.067 0.94 1.211
Organism .312 1.048 0.956 1.148
Blood infection .312 1.048 0.956 1.148
Septic shock .0001 NA* NA* NA*
APACHE II at diagnosis .182 1.143 0.88 1.385
APACHE, Acute Physiology and Chronic Health Evaluation; BITA, bilateral internal
thoracic artery; CABG, coronary artery bypass grafting; CI, confidence interval;
COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; LOS, length
of stay; NA, not applicable; OR, odds ratio. *Risk estimate cannot be performed
because of the singularity of the event and nonoccurrence in the nonevent of the
analyzed factor (2 empty cells in the contingency table). Variables were recorded
at the time of mediastinitis diagnosis.
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more than 60 days to sterilize the mediastinal cultures.
The mean time from flap procedure to hospital discharge
was 5 days.
Reintervention for recurrent wound infection occurred in
2 patients (4.5%) 8 and 12 days after pectoralis flap wound
closure. Both patients had a superficial wound infection
without sternal involvement. Dehiscence was localized on
the distal third of the wound. Patients were readmitted to
the operating room. After debridement of the presternal tis-
sues, NPWT was restarted until wound closure. Both pa-
tients had chronic renal failure and were treated with
dialysis. Univariate analysis showed septic shock to be the
only independent risk factor (P<.0001) for mediastinitis-
related death (Table 2), and dialysis was found to be the
only independent factor (P < .0001) for reintervention
(Table 3).
DISCUSSION
Several strategies have been described to improve the
outcome of PSM, but optimal management is still contro-
versial. The open wound approach allows infection control
by serial dressing changes, but it has high mortality rate, up
to 45%, and major complications related to the manage-
ment of an open sternum limited the use of this strategy.
Since 1963, the closed approach has been the treatment
of choice in many centers.18,19 The primary closed RedonThe Journal of Thoracic and Cardrainage technique received a large consensus, improving
the mediastinitis mortality rate of approximately 20% in
the last decade series.20,21 Age, operations other than
CABG alone, McCabe class 2/3, APACHE II score,
prolonged mechanical ventilation, persistently positive
bacteremia, and MRSA mediastinitis were identified as
mortality risk factors with this approach.13,20
On the other hand, Molina and colleagues22 combined
irrigation and suction with the primary closure technique
and obtained excellent results. The success rate was 98%,
with no mortality. In contrast with these excellent results,
there was an aggressive irrigation flow rate of approxi-
mately 400 mL/h (9600 mL/d) for 7 days with delayed pa-
tient mobilization.
Douville and co-workers23 modified the traditional open
dressing approach. They suggested that wound debridement
and sternal rewiring followed by delayed closure of prester-
nal tissues could be effective in mediastinitis treatment and
reported a mortality rate of 14%.
Since the introduction of VAC by Argenta andMorykwas
in 1997,10 the device has become a widely accepted option
in the management of chronic and difficult wounds. During
the last decade, several studies have reported the successful
use of VAC therapy in mediastinitis treatment,24,25 and
currently it is widely used as the first-line approach to this
complication. The Lund University group26 reported excel-
lent results with VAC therapy in terms of safety, failure rate,
and survival compared with conventional treatment. More-
over, several effects on wound environment have been
described. VAC therapy increases muscle blood flow27,28
and reduces fluid excess and bacterial colonization, which
in turn promote granulation tissue and accelerate wound
healing.
Despite the mortality rate improving from 50% to 10%
to 15% according to recent studies,11-20 the outcome of
PSM is still unpredictable. With the exception of urgent
debridement and culture-guided antibiotic regimen, optimal
treatment is still controversial.
This report analyzed a cohort of 44 consecutive patients
with mediastinitis with a mediastinitis-related mortality of
2.2%. Our protocol was based on 2 different stages. The
first stage was characterized by urgent wound debridement
and NPWT until wound sterilization, and the second stage
was based on elective chest wall closure by pectoralis major
muscle advancement flap.
Data analysis of our population showed a radical gain in
patients’ clinical status during the early phase of the first
stage of treatment, changing the severity of the average clin-
ical condition and in turn allowing a satisfactory recovery
rate. Statistical analysis showed a significant improvement
of APACHE II score 24 hours after wound debridement
andNPWTapplication, independently of any other variables
included in the study (Table 1). The only mediastinitis-
related death was in a patient in septic shock at the time ofdiovascular Surgery c Volume 148, Number 5 2401
TABLE 3. Univariate analyses of need for reintervention
Variable P OR
Lower
CI limit
Upper
CI limit
Age .118 0.88 0.761 1.017
Sex .363 1.094 0.988 1.211
Diabetes .155 1.125 0.985 1.285
Obesity .22 0.901 0.799 1.014
COPD .845 0.781 0.065 9.34
Creatinine>2 .144 5.455 0.449 66.31
Dialysis .00001 NA* NA* NA*
Vasculopathy .476 0.921 0.839 1.011
Transfusion .807 0.733 0.06 8.915
Anemia .807 0.733 0.6 8.915
BITA .496 0.432 0.036 5.145
Other than CABG alone .721 0.639 0.054 7.617
ICU recovery .57 0.925 0.847 1.01
Inotrope .91 0.867 0.072 10.382
Organism .55 0.476 0.04 5.671
Blood infection .55 0.476 0.04 5.671
Septic shock .784 0.93 0.857 1.011
APACHE II at diagnosis .398 0.917 0.831 1.012
APACHE, Acute Physiology and Chronic Health Evaluation; BITA, bilateral internal
thoracic artery; CABG, coronary artery bypass grafting; CI, confidence interval;
COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; NA, not
applicable;OR, odds ratio. *Risk estimate cannot be performed because of the singu-
larity of the event and nonoccurrence in the nonevent of the analyzed factor (2 empty
cells in the contingency table). Variables were recorded at the time of mediastinitis
diagnosis.
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ture, age, type of previous cardiac surgery, persistently pos-
itive bacteremia, severity of illness, and cultures positive for
MRSAwere identified as mediastinitis mortality risk factors
at the time of the diagnosis.13,14,21 Even if comparison with
other studies might not be fully appropriate, in our series,
none of these variables influenced the outcome, which is
instead heavily conditioned by septic shock.
PMV after wound debridement has been identified as a
strong mortality risk factor in patients with mediastinitis,
with a 20-fold increase in mortality rate. In a large series,
showed that patients weaned from the ventilator within 3
days after surgery had a low mediastinitis mortality rate
(2%) regardless of the association with other mediastini-
tis mortality risk factors, highlighting the importance of this
phase in the outcome of this complication. Extensive
debridement and primary closure, as performed in the
conventional closed technique, represent an aggressive
approach that might per se contribute to PMV in such a crit-
ical population. On the contrary, NPWT minimizes surgical
invasiveness at the time of debridement. Repeated dressing
changes and continuous wound drainage, ensured by the
vacuum, allow effective infection control and avoid exten-
sive debridement and wide exposure of bleeding and viable
tissues. Moreover, negative pressure applied to the sponge
immediately restores an effective sternal stabilization,
promoting the contribution of a stable sternum to the2402 The Journal of Thoracic and Cardiovascular Surrespiratory function without the need for more complex sur-
gical solutions. In our series, except for 1 patient in septic
shock at the time of mediastinitis diagnosis who required
mechanical ventilation before debridement, no patients
required mechanical ventilation or ICU stay for more than
12 hours after NPWT.
We used the APACHE II score because it efficiently acts
as a single parametric value of the overall clinical status.
The analysis of all values constituting the APACHE II score
demonstrated that respiratory function, hemoglobin, and
electrolytes were invariably normalized immediately after
NPWT, showing how this treatment affects the clinical sta-
tus of patients in a short time frame. This approach contrib-
utes to clinical recovery, promoting effects of medical
therapy in terms of blood transfusion, hydroelectrolytic bal-
ance, mobilization, and so forth.
The time required to sterilize mediastinal cultures was
20.3  35 days. During this period, complete mobilization
and general parameters normalization were progressively
achieved, allowing chest wall reconstruction with a more
complex surgical approach in patients. Negative pressure
wound closure without muscle flaps has been described
in patients with compromised conditions or atrophied tis-
sues who could not tolerate surgical closure.29,30 We
used this approach in patients with recurrence of
superficial dehiscence after the flap procedure, who had a
problematic re-closure as the result of severely atrophied
presternal tissues.
In our series, wound closure was performed by elective
sternal reapproximation and pectoralis muscle flap. At the
time of culture sterilization, the wound appeared clean
and granulating, but dead space was generally too large
and presternal tissues were too stiff to be sutured in a stan-
dard fashion. A pectoralis muscle advancement flap was
needed to fill the presternal dead space, minimizing ten-
sions on the sutures. Sternal rewiring was feasible in all pa-
tients with 6 to 8 single interrupted wires. In the majority of
patients, wires were positioned only in the anterior surface
of the sternum to avoid further dissections or organs injury.
Fibrotic tissue growth below the sternum significantly re-
duces sternal mobility, contributing to a stable osteosynthe-
sis without the need for adjunctive devices.
Study Limitations
This is a retrospective study conducted in a relatively
small sample of patients. However, we describe the whole
experience in the treatment of mediastinitis at a single cen-
ter over a 6-year period. Data were collected prospectively
in a dedicated database, and the same surgeon performed all
procedures. Before 2006, the approach to mediastinitis was
based on open packing or closed drainage depending on the
surgeon’s preferences, and data were not collected prospec-
tively. This aspect prevented us from performing a compar-
ative study.gery c November 2014
Salica et al Perioperative ManagementCONCLUSIONS
A simple and light wound debridement with sternal stabi-
lization by NPWT is fundamental for early postoperative
mobilization. In a short time frame, this allows a significant
improvement in clinical status as determined by the
APACHE II score. Wound sterilization and complete clin-
ical recovery were invariably achieved before surgical
closure. In this setting, sternal rewiring and pectoralis mus-
cle advancement flap has proven to be safe and effective
with an optimal cosmetic result and a high success rate.
With this approach, septic shock at the time of diagnosis
has been identified as the only independent risk factor for
mediastinitis-related mortality.References
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